Topic: United States

Intensive diabetes treatments give mixed results

CHICAGO (Reuters) - Aggressive drug treatment to lower blood sugar, blood pressure and cholesterol in diabetics does little to prevent heart disease and strokes, but it does help prevent diabetic eye disease, nerve and kidney disease, U.S. researchers said on Tuesday. The ...
Johnson & Johnson is grabbing for a share of the huge, fast-growing market for diabetes drugs, announcing a pair of partnerships Tuesday that could produce novel medicines for the disease. They would complement a very successful line of blood sugar testing and ...

Eating eggs doesn't seem to up diabetes risk

NEW YORK (Reuters Health) - An egg a day for breakfast probably won't increase your likelihood of developing type 2 diabetes, according to a new study. In the study, researchers failed to see a significant association between eating eggs occasionally or almost ...

Brown rice eaters have lower risk of diabetes: study

NEW YORK (Reuters Life!) - People who eat brown rice or other whole grains seem to have a lower risk of developing diabetes than those who eat white rice, according to a U.S. study. A team of researchers from the Harvard School ...

Use of proposed diabetes test may depend on race

NEW YORK (Reuters Health) - A new test to diagnose diabetes, recommended earlier this year by the American Diabetes Association, may not work well in black Americans, according to new research. The study, published in the Annals of Internal Medicine, shows that ...

Those who eat brown rice may have less diabetes

NEW YORK (Reuters Health) - Among rice lovers, people who eat brown rice or other whole grains seem to have a lower risk of developing diabetes than those who eat white rice, Boston-based researchers said on Monday. Among more than 197,000 US ...

Vitamin K linked to lower diabetes risk

NEW YORK (Reuters Health) - People who get plenty of vitamin K from food may have a lower risk of developing type 2 diabetes than those who get less of the vitamin, a new study suggests. Researchers found that among more than ...
Merck & Co. is enjoying a spurt of new drug launches, partly due to its $41 billion November acquisition of New Jersey neighbor Schering-Plough Corp. Some have been on the market in the United States for a while, including blockbuster diabetes medicine ...
Southern California parents get long sentences for death of neglected diabetic daughterA Southern California couple convicted of murder after their teenage daughter slipped into a diabetic coma and died have been sentenced to prison. Riverside County Judge Raymond Youngquist on Friday sentenced ...

U.S. group urges FDA to halt Glaxo's Avandia trial

WASHINGTON (Reuters) - An major trial of Avandia puts patients at risk and should be stopped, a U.S. advocacy group said on Tuesday, calling on regulators to immediately halt the global study of the controversial GlaxoSmithKline Plc diabetes drug. The U.S. Food ...